Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Artiva Biotherapeutics is seeking a Temporary QA Compliance Associate II/III to support quality and cGMP compliance as we advance our cell therapies. You will review data, maintain records, and help ensure audits and regulatory compliance in a fast-paced biotech environment.
The role requires 3–5+ years in an FDA-regulated setting and a Bachelor’s degree, with level II/III distinctions based on experience. Join our growing Quality team to impact lot disposition, deviations, CAPAs, and change
About Artiva:
We are a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies. Our mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases. We aim to develop therapies that patients and physicians can utilize in a community setting. Our lead product candidate, AlloNK®, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs). We believe the compelling cell-killing properties of NK cells, when combined with mAbs for targeting, create an opportunity to generate potentially transformative therapies.
For more information, visit www.artivabio.com.
Join Artiva Biotherapeutics as a Temporary QA Compliance Associate II/III and play a key role in supporting quality and cGMP compliance as we advance our innovative cell therapies. We're seeking a detail-oriented quality professional with 3–5+ years of experience in an FDA-regulated environment who thrives in a fast-paced, collaborative biotech setting. Bring your compliance expertise, contribute to continuous improvement, and make a meaningful impact within our growing Quality team. Experience supporting Cell Therapy Manufacturing is a plus! You will be responsible for Quality Assurance Compliance activities supporting lot disposition, quality events, and development/qualification raw data review.